KYOWA HAKKO BIO CO.,LTD.
KYOWA HAKKO BIO CO., LTD., a prominent player in the pharmaceutical preparation manufacturing industry, is headquartered in Japan. Established in 1949, the company has made significant strides in biopharmaceuticals, focusing on the development and production of high-quality pharmaceuticals and healthcare products.
With a strong presence in both domestic and international markets, KYOWA HAKKO BIO is renowned for its innovative bioprocessing technologies and commitment to quality. The company’s core offerings include amino acids, biopharmaceuticals, and fermentation-derived products, which are distinguished by their purity and efficacy.
Recognised for its contributions to the pharmaceutical sector, KYOWA HAKKO BIO has achieved notable milestones, solidifying its market position as a trusted provider of advanced biopharmaceutical solutions.
+33 vs industry average
KYOWA HAKKO BIO CO.,LTD.’s score of 71 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at KYOWA HAKKO BIO CO.,LTD.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2026
Reported emissions
Scope 3 accounts for ••• of total emissions.
KYOWA HAKKO BIO CO.,LTD.'s reported carbon emissions
KYOWA HAKKO BIO CO.,LTD., headquartered in Japan and operating in the Pharmaceutical Preparation Manufacturing industry, has established climate commitments and reported its carbon emissions. For the reporting year 2023, the company reported total Scope 1 and 2 emissions of approximately 129,000,000 kg CO2e, with Scope 1 emissions standing at approximately 33,000,000 kg CO2e and Scope 2 emissions at approximately 96,000,000 kg CO2e. Scope 3 emissions for 2023 were approximately 176,000,000 kg CO2e. Looking at previous years, in 2022, KYOWA HAKKO BIO CO.,LTD. reported total Scope 1 and 2 emissions of approximately 170,000,000 kg CO2e, with Scope 1 emissions at approximately 40,000,000 kg CO2e and Scope 2 emissions at approximately 131,000,000 kg CO2e. Their Scope 3 emissions in 2022 were approximately 193,000,000 kg CO2e. In 2021, Scope 1 and 2 emissions totalled approximately 202,000,000 kg CO2e (Scope 1: 41,000,000 kg CO2e; Scope 2: 161,000,000 kg CO2e), with Scope 3 emissions at approximately 190,000,000 kg CO2e. For 2020, Scope 1 and 2 emissions were approximately 219,000,000 kg CO2e (Scope 1: 44,000,000 kg CO2e; Scope 2: 175,000,000 kg CO2e), and Scope 3 emissions were approximately 189,000,000 kg CO2e. In 2019, Scope 1 and 2 emissions were approximately 243,000,000 kg CO2e (Scope 1: 47,000,000 kg CO2e; Scope 2: 196,000,000 kg CO2e), with Scope 3 emissions at approximately 234,000,000 kg CO2e. Earlier data from 2005 indicates Scope 1 emissions of approximately 601,000,000 kg CO2e, with Scope 2 and 3 emissions not reported for that year. KYOWA HAKKO BIO CO.,LTD. is aiming for significant reductions in its greenhouse gas (GHG) emissions. The company has set a target for a 50% reduction in Scopes 1 and 2 emissions and a 30% reduction in Scope 3 emissions by 2030, using 2019 as the baseline year. It is noted that KYOWA HAKKO BIO CO.,LTD. is a current subsidiary and its emissions data may be cascaded from its parent organization, Kyowa Hakko Bio Co., Ltd. The company's climate initiatives, including SBTi, CDP, RE100, and RTZ, are reportedly aligned with Kirin Holdings Company, Limited.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
KYOWA HAKKO BIO CO.,LTD.’s Climate Goals (2030 & 2050)
2 goals2030
50% reduction in all scopes
aiming for a 50% reduction in Scopes 1 and 2 and a 30% reduction in Scope 3 emissions by 2030, all compared to 2019 levels.
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 2 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Kirin Holdings Company, Limited
Carbon Disclosure Project
Inherited from Kirin Holdings Company, Limited
The Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Kirin Holdings Company, Limited
RE 100
Inherited from Kirin Holdings Company, Limited
Climate Action 100
Emissions comparison with industry peers
View similar organisations
KYOWA HAKKO BIO CO.,LTD.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project